Legislative Radar
Kratom legislation across all 50 states.
Tracking bills that could affect access to kratom and kratom alkaloid products. AI classifies each bill on three axes — direction, severity, imminence — using the actual bill text. Updated weekly.
National Legislative Threat Summary
36 states with active legislation · 110 total bills tracked
All Tracked Bills
Kratom Adjustments
S.B. 45 restructures Utah's kratom regulation by (1) scheduling 7-hydroxymitragynine and Mitragynine pseudoindoxyl as Schedule I controlled substances, (2) banning kratom extracts and products exceeding 0.4% 7-HM, (3) restricting retail sales to licensed tobacco specialty businesses with department registration, and (4) raising the legal purchase age to 21. The bill creates a narrow window for "pure leaf kratom" compliant with purity standards but effectively eliminates most commercial kratom products and subjects violators to class B misdemeanor (first), class A misdemeanor (second), and felony (subsequent) charges.
Kratom Revisions
S.B. 48 amends Utah's controlled substances schedules to classify 7-hydroxymitragynine (when concentration exceeds 0.4% of total kratom alkaloid composition) and Mitragynine pseudoindoxyl as Schedule I controlled substances. It also tightens kratom processor requirements, banning synthetic alkaloids and products exceeding the 7-hydroxymitragynine threshold. The bill takes effect May 6, 2026, unless passed by supermajority for earlier enactment.
Kratom products; narcotic drugs
HB 2415 amends Arizona's drug laws to classify kratom products containing at least 800 parts per million of 7-hydroxymitragynine or any synthetic kratom alkaloids as narcotic drugs under A.R.S. § 13-3401(20)(jjj). This reclassification makes kratom possession a felony and retail sales illegal. The bill also repeals the prior kratom regulatory section 36-795.01 and replaces it with new regulations, effectively eliminating kratom as a legal consumer product in Arizona.
Regulate Hemp-Derived Consumables
North Carolina HB 328 creates comprehensive regulation of hemp-derived consumable products (delta-9 THC products ≤0.3%), establishing licensing, testing, labeling, age-21 restrictions, and child-resistant packaging requirements. Critically, Part IV adds kratom (mitragynine/7-hydroxymitragynine from Mitragyna speciosa) to Schedule VI controlled substances, making it illegal to possess, sell, manufacture, or distribute kratom effective December 1, 2025.
Further providing for schedules of controlled substances.
SB 899 adds kratom-specific prohibitions to Pennsylvania's Controlled Substance Act. Section 13(a)(41) bans sale of kratom products to minors that contain contaminants, synthetic alkaloids, excessive 7-hydroxymitragynine (>2% alkaloid fraction), high residual solvents, or inadequate labeling. Section 4(1)(IX) schedules as Schedule I any kratom material with 7-hydroxymitragynine ≥2% total alkaloid content or ≥1mg per serving, plus all synthetic/semi-synthetic mitragynine forms.
Banning the sale of kratom
Senate Bill 1558 proposes to ban the sale of kratom in Massachusetts. The bill characterizes kratom as a herbal substance capable of producing opioid- and stimulant-like effects and seeks legislative prohibition of its retail sale. The bill is currently in the Joint Committee on Public Health with an extended reporting deadline of July 31, 2026.
END 7-OH Act End Needless Distribution of 7-OH Act
H.R. 8000 amends the Controlled Substances Act to classify synthetic 7-hydroxymitragynine as a Schedule I controlled substance. The bill creates a carve-out preserving natural 7-hydroxymitragynine in whole kratom plant (Mitragyna speciosa) from Schedule I status, but targets isolated, concentrated, or synthetically produced forms of this alkaloid.
An Act To Amend Title 16 Of The Delaware Code Relating To The Uniform Controlled Substances Act.
SB 262 amends Delaware's Uniform Controlled Substances Act to classify kratom, mitragynine, 7-hydroxymitragynine, and kratom products as Schedule I controlled substances. The bill criminalizes manufacturing, distributing, and selling kratom products as a Class C felony, and makes personal possession above 30 grams a Class B misdemeanor subject to fines but not incarceration for first offenses.
Amends existing law to provide that certain substances involving mitragynine shall be Schedule I controlled substances.
Idaho House Bill 864 amends the uniform controlled substances law to classify mitragynine and three related alkaloids (mitragynine pseudoindoxyl, 7-hydroxy mitragynine, and dihydro-7-hydroxy mitragynine) as Schedule I controlled substances, effective July 1, 2026. This classification makes kratom products illegal to possess, manufacture, or distribute in Idaho. The bill was introduced by the State Affairs Committee but has not advanced past first reading.
Amends existing law to provide that alkaloids found in or derived from Mitragyna speciosa shall be a Schedule I controlled substance.
House Bill 830 amends Idaho Code § 37-2705 to classify all alkaloids found in or derived from Mitragyna speciosa (kratom) as Schedule I controlled substances, effective July 1, 2026. This includes synthetic alkaloids, homologs, analogs, isomers, esters, ethers, salts, and related derivatives. The bill declares an emergency to accelerate implementation.
Kratom classified as a Schedule II controlled substance.
H.F. 3452 reclassifies kratom and its primary alkaloids (mitragynine and 7-hydroxymitragynine) as Schedule II controlled substances under Minnesota law. The bill amends section 152.02 to add kratom to the Schedule II list and repeals section 152.027 subdivision 7, which previously allowed sales to adults while restricting sales to minors. This converts kratom from a legal botanical product into a controlled drug subject to pharmacy-only dispensing and criminal penalties.
Kratom classification as a Schedule II controlled substance
S.F. 3711 would classify kratom's primary alkaloids (mitragynine and 7-hydroxymitragynine) as Schedule II controlled substances under Minnesota law. The bill repeals the existing age-of-sale restriction statute (Minn. Stat. §152.027, subd. 7) and replaces it with full criminal prohibition. This conversion from a regulated substance to a Schedule II drug would eliminate all legal kratom access in Minnesota.
Kratom-prohibition.
HB0185 would impose a complete prohibition on kratom (mitragyna speciosa) in Wyoming, criminalizing manufacture, sale, distribution, and possession of all kratom products. The bill cites DEA listings, FDA recommendations on concentrated alkaloids, a 41-state salmonella outbreak, and rising poison control encounters as justification. Violations are misdemeanors with escalating penalties, and kratom products become forfeitable contraband.
UNREGULATED SUBSTANCE BAN
HB4930 creates the Protect Communities from Unregulated Substances Act, which prohibits the sale, distribution, manufacture, or dispensing of kratom and tianeptine products unless approved by the FDA. The bill imposes civil penalties of $10,000 per violation and authorizes the Attorney General to enforce the prohibition. Since no kratom products are FDA-approved for human use, this effectively bans kratom retail in Illinois.
Prohibits the possession and sale of certain mitragynine-derived products
HB 3173 amends Missouri law to prohibit the possession, preparation, sale, distribution, and advertisement of mitragynine-derived products—defined as those containing mitragynine pseudoindoxyl or alkaloid-fraction levels of 7-hydroxymitragynine exceeding 2%. The bill creates a narrow exemption for scientific and medical research at accredited institutions. This effectively bans enhanced or concentrated kratom products while potentially targeting standard kratom if formulated above the 2% 7-OH threshold.
KRATOM PROHIBITION ACT
SB3160 creates the Kratom Prohibition Act, which bans the purchase, possession, sale, and distribution of all kratom products for any person. Violations are Class B misdemeanors, with a minimum $500 fine for sales. The bill repeals the existing Kratom Control Act and authorizes local health departments to enforce the prohibition.
Ban kratom and kratom products and to provide a penalty therefor.
House Bill 1151 would completely ban kratom and kratom products in South Dakota, making purchase, sale, distribution, possession, and consumption criminal offenses punishable as Class 2 misdemeanors. The bill repeals existing age-of-sale (21+) and product-quality regulations, replacing them with a comprehensive prohibition. No exceptions are provided for adult use.
Further providing for schedules of controlled substances.
Pennsylvania House Bill 2158 proposes to add kratom and its alkaloids to Schedule I of the state's Controlled Substance, Drug, Device and Cosmetic Act. The bill targets natural kratom, synthetic mitragynine, 7-hydroxymitragynine, and related alkaloid derivatives, defining them by concentration thresholds (≥2% total alkaloid content or ≥1 mg per serving). If enacted, this would make kratom a Schedule I controlled substance in Pennsylvania, eliminating legal access.
Relating to Kratom
HB 4459 eliminates West Virginia's kratom regulatory statute (the Select Plant-Based Derivatives Regulation Act) and reclassifies kratom and all its alkaloids—including mitragynine and 7-hydroxymitragynine—as Schedule I controlled substances. This converts kratom from a regulated commodity into an illegal drug, eliminating all lawful manufacture, sale, and possession.
Prohibits the sale of products that contain 7-hydroxymitragynine at a level that exceeds 2% of total alkaloids or one milligram per serving; establishes fines for the sale of such products.
Senate Bill S08925 amends New York General Business Law to prohibit the sale of products containing 7-hydroxymitragynine above 2% of total alkaloids or 1mg per serving. Violators face civil penalties of $3,000 for first offense and $6,500 for subsequent violations, with collected funds directed to the state drug treatment and education fund. The bill would become effective 90 days after enactment.
AN ACT to amend Tennessee Code Annotated, Title 33, Chapter 2; Title 38; Title 39; Title 50; Title 63 and Title 68, relative to Kratom.
This bill would criminalize kratom in Tennessee by making possession a felony, manufacture/delivery/sale felonies with enhanced penalties for sales to minors, and requires medical examiners and physicians to test for kratom in overdose and neonatal abstinence cases. The bill deletes an existing exemption for kratom and directs the labor commissioner to add kratom to the statutory definition of a drug.
AN ACT to amend Tennessee Code Annotated, Title 33, Chapter 2; Title 38; Title 39; Title 50; Title 63 and Title 68, relative to Kratom.
Tennessee SB 1656/HB 1649 ("Matthew Davenport's Law") would criminalize all possession, manufacture, delivery, and sale of kratom effective July 1, 2026. The bill establishes Class A misdemeanor penalties for possession and Class C felonies (Class B if sold to minors) for distribution. Additionally, it mandates kratom testing in overdose autopsies and suspected neonatal abstinence cases, and directs the state labor commissioner to add kratom to the controlled drug definition.
AN ACT to amend Tennessee Code Annotated, Title 33, Chapter 2; Title 38; Title 39; Title 50; Title 63 and Title 68, relative to Kratom.
Tennessee HB 1647/SB 1655 ('Matthew Davenport's Law') would criminalize all possession, manufacture, and sale of kratom, including extracts and synthetic analogs, as felonies. The bill mandates kratom testing in drug-overdose autopsies and toxicology panels for suspected overdose and neonatal abstinence syndrome. It removes kratom from a prior medical-use exemption and directs the labor commissioner to add kratom to the drug definition for workplace testing purposes.
Controlled substances; mitragynine and hydroxymitragynine (7-OH) are Schedule I; provide
Georgia HB 968 (SUB) schedules kratom alkaloids as Schedule I controlled substances while ostensibly allowing regulated sales via licensed pharmacists behind counters with real-time electronic logging starting January 2027. The bill prohibits compressed/tablet forms, multi-serving packaging, vaping devices, and synthetic derivatives, imposing felony penalties (1–15 years imprisonment, up to $100,000 fines) on processors and retailers for knowing or negligent violations. This represents a de facto ban disguised as regulatory control.
AN ACT to amend Tennessee Code Annotated, Title 33, Chapter 2; Title 38; Title 39; Title 50; Title 63 and Title 68, relative to Kratom.
This Tennessee bill (HB 1649/SB 1656) enacts a total prohibition on kratom by criminalizing possession, manufacture, delivery, and sale. It removes kratom from a medical exemption, mandates toxicology testing for kratom in overdose and neonatal abstinence cases, and instructs the labor commissioner to classify kratom as a drug. The law takes effect July 1, 2026.
"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.
S.829 ('CJ's Law') would criminalize the manufacture, distribution, sale, and possession of kratom (Mitragyna speciosa) as a controlled dangerous substance in New Jersey. Offenses range from second-degree felonies (distribution of ≥1 oz, 5–10 years imprisonment) to fourth-degree misdemeanors (simple possession <1 oz, up to 18 months). The bill cites FDA warnings about kratom's opioid-like effects and references a single death allegedly linked to kratom combined with prescribed Adderall.
"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.
Assembly Bill 1203 ('CJ's Law') would criminalize the manufacture, distribution, and possession with intent to distribute kratom and its derivatives in New Jersey. Violations would constitute felonies: second-degree crimes for quantities ≥1 ounce and third-degree crimes for <1 ounce. The bill exempts licensed practitioners (physicians, dentists, veterinarians, researchers, laboratories, pharmacies, and hospitals).
Classifies 7 Hydroxymitragynine as Schedule I drug and bans sale of products containing substance.
Assembly Bill 1636 classifies 7-hydroxymitragynine (7-OH), a concentrated kratom alkaloid, as a Schedule I controlled dangerous substance in New Jersey and bans all sale, manufacture, and distribution of products containing it. Violations trigger escalating felony charges (fourth to second degree) and mandatory product destruction; manufacturers and retailers face criminal liability and consumer fraud penalties.
Ban kratom and kratom products and to provide a penalty therefor.
Senate Bill 77 would criminalize all kratom-related activity in South Dakota, making it a Class 2 misdemeanor to sell, distribute, purchase, consume, or possess kratom or kratom products. The bill repeals existing age-of-sale and product-quality regulations (§§ 34-20B-115 and 34-20B-115.1), replacing them with a categorical prohibition. This represents a shift from harm-reduction regulation to total prohibition.
"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.
CJ's Law would criminalize kratom (Mitragyna speciosa) by adding it as a controlled dangerous substance under N.J.S.2C:35-2, making manufacture, distribution, and possession criminal offenses with felony penalties ranging from 18 months to 10 years imprisonment. The bill establishes graduated penalties based on quantity (≥1 oz vs. <1 oz) and distinguishes between distribution/manufacture (second and third degree) and simple possession (third and fourth degree crimes).
"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.
S.2271, titled "CJ's Law," would criminalize the manufacture, distribution, dispensing, and possession with intent to distribute of all substances containing kratom and its alkaloids. The bill creates a second-degree felony for quantities of 1 ounce or more and a third-degree felony for smaller amounts, with exceptions only for licensed practitioners. If enacted, it would ban kratom sales and personal production in New Jersey.
Prohibits the sale or offering for sale, delivery or manufacture of food or beverages containing kratom or its derivatives, or 7-hydroxymitragynine; provides penalties.
New York Senate Bill S08686 would amend the General Business Law to prohibit the sale, offer for sale, manufacture, or delivery of any food or beverage product containing kratom or 7-hydroxymitragynine, effective January 1, 2027. Violations carry civil penalties of $500 for first offense and up to $1,000 for subsequent violations. The bill has a one-year implementation window from enactment.
Prohibits the sale of products that contain 7-hydroxymitragynine at a level that exceeds 2% of total alkaloids or one milligram per serving; establishes fines for the sale of such products.
This bill amends New York General Business Law to prohibit the sale of any kratom product containing 7-hydroxymitragynine above 2% of total alkaloids or 1 milligram per serving. Violators face civil penalties up to $3,000 for first offense and $6,500 for subsequent violations, with funds directed to the state drug treatment fund. The bill targets concentrated or enriched kratom products rather than traditional leaf.
Prohibits the sale or offering for sale, delivery or manufacture of food or beverages containing kratom or its derivatives, or 7-hydroxymitragynine; provides penalties.
Assembly Bill A09114 would prohibit the sale, offer for sale, manufacture, and delivery of any food or beverage product containing kratom or 7-hydroxymitragynine in New York State. The ban takes effect January 1, 2027, and violators face civil penalties of $500 for first offense and $1,000 for subsequent violations.
A RESOLUTION relative to the regulation of Kratom.
HJR 147 is a non-binding resolution expressing legislative support for either strict kratom regulation or an outright ban in Tennessee. The resolution cites public health concerns including 2,000+ reported overdose deaths (2021–2023), lack of product standardization, and a fatal drug interaction case to justify the call for state action.
A RESOLUTION relative to the regulation of Kratom.
SJR 346 is a non-binding resolution urging Tennessee to either heavily regulate or completely ban the sale of kratom in the state. The resolution cites health concerns including 2,000+ fatal kratom-related overdoses nationally (2021–2023), lack of product standardization, and a specific death attributed to kratom-medication interaction. It frames kratom as an unregulated compound equivalent to 'gas station heroin' despite its legal status.
Relative to a ban on Kratom
H.1680 is a bill introduced by Rep. Rodney Elliott and Co-sponsor Colleen Garry to establish kratom as a controlled substance in Massachusetts. The bill was referred to the Judiciary Committee, received a hearing in May 2025, and was subsequently reported with a study order in March 2026, indicating the committee did not advance it for a floor vote.
The scheduling of mitragynine as a schedule I controlled substance.
HB 1101 amends North Dakota Century Code section 19-03.1-05 to schedule mitragynine and its variants (including kratom) as Schedule I controlled substances. The bill explicitly lists mitragynine under item (ee) as "also known as 7-hydroxymitragynine and Kratom," placing it alongside fentanyl derivatives and other opioid analogs. If enacted, kratom would be illegal to possess, sell, or distribute in North Dakota.
Relating to adding certain substances to the Texas Controlled Substances Act and regulating kratom and kratom products; increasing civil penalties; creating criminal offenses; increasing a criminal penalty.
SB1868 would add certain substances to Texas's controlled substances list and establish regulatory requirements for kratom and kratom products, while increasing civil penalties and creating or enhancing criminal offenses related to these substances. The bill would affect kratom vendors, retailers, and consumers in Texas by imposing new compliance obligations and legal consequences. The specific regulatory framework and which substances would be added are not detailed in the available bill description.
Kratom Modifications
Utah H.B. 387 modifies the existing Kratom Consumer Protection Act by banning kratom extracts, raising the minimum purchase age from 18 to 21, requiring all processors and retailers to register with the Department of Agriculture and Food, and dramatically escalating criminal penalties for violations from Class C misdemeanors to Class B/A misdemeanors and felonies. The bill also suspends the entire regulatory framework if all alkaloids in Mitragyna speciosa become scheduled controlled substances under state law.
Provides with respect to the possession of Kratom
HB 778 amends Louisiana's kratom laws by removing the blanket prohibition on all kratom and instead permitting natural kratom products that comply with alkaloid limits (≤2% 7-hydroxymitragynine, ≤80mg mitragynine per serving) while criminalizing possession and distribution of synthetic kratom and non-compliant products. The bill defines synthetic kratom derivatives and establishes tiered penalties based on quantity and intent.
Taxing kratom.
SB 6196 imposes a 95% excise tax on all kratom products in Washington state, effective January 1, 2027, and creates a mandatory licensing regime for distributors and retailers enforced by the Liquor and Cannabis Board. Revenue from the tax flows to a youth harmful substance prevention account. The bill includes criminal penalties (Class C felony for unlicensed distribution, gross misdemeanor for transport violations), warrantless inspections, and product seizure and forfeiture authority.
Kratom products; modifying certain definitions; removing certain packing and labeling requirements. Effective date.
Oklahoma Senate Bill 891 amends the Oklahoma Kratom Consumer Protection Act to refine definitions of kratom leaf, kratom leaf extract, and kratom products; remove certain prior packaging/labeling burdens while clarifying labeling requirements; and require vendors to provide independent laboratory test results to the Department of Health upon request to verify label claims. The bill legitimizes kratom as a regulated consumer product while maintaining safeguards against contamination and adulteration.
Adds to existing law to establish the Idaho Kratom Consumer Protection and Safety Act.
Idaho SB 1418 establishes the Kratom Consumer Protection and Safety Act, legalizing and regulating natural kratom products for adults 21+ while prohibiting adulterated, chemically enhanced, and synthetic products. The law preempts all local jurisdictions from imposing stricter standards, requires processors to comply with federal GMP standards and disclose testing certifications, mandates product labeling with ingredient lists and warning statements, and authorizes enforcement through civil penalties and product seizure.
Kratom product regulation.
Wyoming's Kratom Product Regulation Act (2026) legalizes and regulates kratom as a food or dietary supplement while prohibiting sales to persons under 21, adulterated products (those containing synthetic or semi-synthetic alkaloids), and products exceeding 2% 7-hydroxymitragynine. The state chemist and Department of Health are tasked with testing and enforcement, with penalties of up to 1 year imprisonment and $1,000 fines for violations; retailers may face injunctions on third or subsequent violations within two years.
Kratom
CS/HB 1205 creates the Florida Kratom Consumer Protection Act, legalizing kratom products for adults 21+ and requiring independent laboratory certification, strict testing protocols (7-hydroxymitragynine limits, contaminant screening), compliant packaging, and delivery-sale age verification. The bill also restricts ingestion near schools and authorizes seizure of non-compliant products.
Specialized Product Amendments
I don't have access to the specific text or details of SB0101 (UT) in my current information. To provide you with an accurate, factual summary of what this bill would do regarding kratom or kratom alkaloids, their regulation, and who it would affect, I would need to review the actual bill language. I'd recommend checking the Utah State Legislature's website (le.utah.gov) directly to access the bill text, which would allow me to give you a precise summary of its provisions and impacts.
Public health: kratom.
AB-1088 creates a California Kratom Consumer Protection Program regulating kratom and 7-hydroxymitragynine products through labeling, child-resistant packaging, and age-21 sales restrictions. The bill exempts kratom manufacturers from general food/drug registration while capping 7-hydroxymitragynine concentration and prohibiting child-attractive packaging. This represents a harm-reduction approach that legitimizes the legal kratom market while enforcing consumer safety standards.
Regulate Kratom Products
H.B. 468 creates a comprehensive regulatory scheme for kratom products in North Carolina under the Alcohol Law Enforcement Division, establishing licensing requirements for manufacturers, distributors, and retailers; independent lab testing with high-performance liquid chromatography; strict labeling and packaging standards; age-21 purchase and possession restrictions; and civil/criminal penalties for violations. The bill also prohibits kratom and hemp-derived consumable products on school property and restricts sale of hemp products to those under 21.
Concerning the regulation of kratom
H.2454 aims to regulate kratom by establishing penalties for the sale, preparation, manufacturing, or distribution of kratom products contaminated with dangerous non-kratom substances. The bill treats kratom as a legitimate product requiring safety protections rather than proposing prohibition. It has progressed through committee review and generated a companion bill, suggesting active legislative development.
Enacting the kratom consumer protection act, defining kratom as a food product, prohibiting the distribution and sale of kratom that is adulterated, requiring persons to be at least 21 years of age to purchase such product, establishing civil fines for violations of the act and requiring the secretary of agriculture to adopt rules and regulations for the administration of the act.
HB 2230 enacts a kratom consumer protection act that classifies kratom as a food product, prohibits adulterated kratom distribution and sale, and requires purchasers to be at least 21 years of age. The bill directs the Kansas Secretary of Agriculture to adopt rules and regulations for administration and establishes civil fines for violations.
Relating To Consumer Protection.
SB463 establishes the Hawaii Kratom Consumer Protection Act, requiring kratom products to register with the Department of Health and comply with labeling requirements effective January 1, 2026. This is a consumer protection and regulatory framework rather than a prohibition, positioning kratom as a legitimate regulated product in Hawaii's marketplace.
Kratom; manufacturing, selling, giving, distributing, or possessing, penalties.
Virginia bill that establishes penalties for manufacturing, selling, giving, distributing, or possessing kratom. The exact scope and severity of penalties cannot be determined from the title alone. This appears to be an early-stage punitive measure rather than a regulatory or consumer-protection framework.
Relative to kratom sales in the Commonwealth
H.4394 is a Massachusetts bill concerning kratom sales that was favorably reported from the House Judiciary Committee in August 2025 and referred to the House Ways and Means Committee. The full text of the bill is not accessible from the provided legislative portal page, preventing detailed analysis of whether it protects or restricts kratom access.
Alcohol, Tobacco, and Cannabis Commission - Unauthorized Consumable Products - Enforcement and Seizure
HB1523 would expand the Alcohol, Tobacco, and Cannabis Commission's enforcement authority to regulate "unauthorized consumable products" beyond alcohol, tobacco, and cannabis, allowing the commission to seize and destroy such products and penalize retailers who sell them. The bill does not specifically name kratom, but depending on how "unauthorized consumable products" is defined in implementation, it could potentially restrict or ban kratom sales in Maryland if kratom is classified as unauthorized. This would primarily affect retailers selling kratom and related alkaloid products in the state.
Alcohol, Tobacco, and Cannabis Commission - Unauthorized Consumable Products - Enforcement and Seizure
SB820 would expand the Maryland Alcohol, Tobacco, and Cannabis Commission's authority to enforce restrictions on "unauthorized consumable products" by allowing them to issue citations, seize products, and destroy inventory. The bill would prohibit retailers from selling or advertising these unauthorized products, though the bill does not specifically define which products fall into this category. Depending on how "unauthorized consumable products" is defined in regulations, this could potentially restrict access to kratom or kratom alkaloid products if they are designated as unauthorized.
AN ACT relating to regulated substances and declaring an emergency.
HB9 would establish a new regulatory licensing fee structure for alcoholic beverages, cannabis-infused beverages, and kratom/hemp-derived/cannabinoid products in Kentucky, imposing state retail fees on these products while creating laboratory testing standards through the Department for Public Health. The bill would also modify existing alcohol licensing rules, allow local governments to impose regulatory fees on these products (with caps), and sunset current excise and wholesale taxes on alcoholic and cannabis beverages by July 1, 2027. This bill would regulate kratom and related alkaloid products through licensing fees and testing standards rather than restricting or banning access.
Relative to kratom
H.5127 is a consolidation of two prior kratom regulation bills (H.2454 and H.4261) reported favorably by the House Judiciary Committee in February 2026. The bill is currently referred to the House Ways and Means Committee. The actual text and specific regulatory provisions are not accessible in the legislative portal excerpt provided.
Concerning the regulation of Kratom
S.1609 is a Massachusetts bill concerning the regulation of kratom, introduced by Jacob R. Oliveira and Colleen M. Garry. The bill is currently in committee with an extended reporting deadline; the full text is not accessible from the legislative docket provided.
An Act To Amend Title 16 Of The Delaware Code Relating To Kratom.
Delaware HB 332 creates a Kratom Consumer Protection Act establishing labeling and quality requirements, banning adulterated/contaminated products and synthetic alkaloids, capping 7-Hydroxymitragynine at 2% of alkaloid composition, restricting sales to age 21+, and prohibiting youth-targeted marketing. The bill also mandates a 2026 health reporting requirement on opioid-like substance adverse events including kratom and tianeptine.
Florida Kratom Consumer Protection Act
SB 994 creates a Florida Kratom Consumer Protection Act establishing regulatory requirements for kratom processors and finished products. Processors must obtain state food permits, register with FDA, maintain product liability insurance, and submit certificates of analysis from accredited third-party labs for each batch. Finished kratom products sold at retail must be age-21+ restricted, labeled with alkaloid content and dosage warnings, and comply with limits on heavy metals, pesticides, and residual solvents.
Creates "New Jersey Kratom Protection Act."
This bill creates the New Jersey Kratom Consumer Protection Act, regulating kratom as a food product subject to labeling, testing, and purity standards. It prohibits sales to persons under 21, requires age verification at point of sale, and bans adulterated or contaminated products, synthetic alkaloids, and products exceeding 2% 7-hydroxymitragynine. Retailers face civil penalties ($500–$1,000) and license suspension (3 years) for violations; the Department of Health shall adopt rules and conduct a health study within one year.
Adds to existing law to establish the Idaho Kratom Consumer Protection and Safety Act.
Senate Bill 1282 creates the Idaho Kratom Consumer Protection and Safety Act, establishing minimal state-level regulation focused on preventing sale of adulterated kratom products (those spiked with synthetic alkaloids, exceeding 2% 7-OH, or containing contaminants) while preserving adult access. The bill mandates age-of-sale checks (18+), labeling requirements, federal GMP compliance certification, and civil enforcement, while preempting stricter local regulations and explicitly prohibiting licensing fees or registration burdens.
AN ACT to amend Tennessee Code Annotated, Title 33; Title 39, Chapter 17, Part 4; Title 43 and Title 57, relative to Kratom.
Tennessee HB 2594/SB 2417, titled the 'Tennessee Kratom Consumer Protection Act,' legalizes kratom sales to adults 21+ while establishing a regulatory framework requiring third-party lab testing, limits on 7-hydroxymitragynine content, heavy metal testing, comprehensive labeling with dosing and warning statements, and prohibitions on synthetic or chemically altered alkaloids. The bill amends TCA Title 39, Chapter 17, Part 4 and takes effect July 1, 2026.
AN ACT to amend Tennessee Code Annotated, Title 33; Title 39, Chapter 17, Part 4; Title 43 and Title 57, relative to Kratom.
Tennessee SB 2417/HB 2594 creates the Tennessee Kratom Consumer Protection Act, legalizing kratom products for adults 21+ and establishing regulatory requirements for processors and retailers. The bill mandates third-party lab testing (Certificate of Analysis), restricts synthetic alkaloids and high 7-hydroxymitragynine products, requires comprehensive labeling with alkaloid content and health warnings, and bans sales to minors. Enforcement falls to the Alcoholic Beverage Commission with penalties ranging from $500 (first violation) to $2,500 (repeat violations) for non-compliance.
KRATOM CONSUMER PROTECTION ACT
HB4737 creates a regulated framework for kratom products in Illinois by prohibiting high-potency and adulterated products, mandating labeling with alkaloid content and health warnings, restricting sales to persons under 21, and requiring quality testing from ISO 17025 laboratories. It repeals the prior Kratom Control Act and preempts local regulation by making kratom regulation an exclusive state power.
Creates new provisions relating to the sale of kratom products
HB 3147 creates the Missouri Kratom Consumer Protection Act, establishing state-level regulation of kratom products (defined as foods containing Mitragyna speciosa leaf) while preempting all local ordinances. The bill requires product labeling disclosing factual basis for kratom representation, prohibits adulteration with dangerous non-kratom substances, restricts synthetic alkaloids and limits 7-hydroxymitragynine to ≤2% of alkaloid fraction, mandates alkaloid content labeling, and sets an 18+ age restriction. Violations range from civil fines ($500–$1,000) to class D misdemeanor charges.
Concerning the preparation, distribution, and sale of kratom products.
SSB 6287 creates a kratom consumer protection act by defining kratom extract, processors, retailers, and synthesized kratom material in RCW 69.50.101, then adds enforcement rules (Sec. 3) prohibiting adulterated, contaminated, or synthetically modified kratom products, requiring full ingredient and alkaloid labeling, and restricting sales to adults 21+. Violations are gross misdemeanor; civil liability available; local governments may impose stricter rules.
Creates new provisions relating to the sale of kratom products
Missouri HB 3067 enacts a 'Kratom Consumer Protection Act' that legalize kratom sales while establishing quality and labeling standards. The bill preempts all local kratom restrictions, permits sales to adults 18 and older, and prohibits adulteration, contamination, synthetic alkaloids, excessive 7-hydroxymitragynine (>2% of alkaloid fraction), and products lacking alkaloid-content labeling. Violations range from civil fines ($500–$1,000 for labeling failures) to Class D misdemeanors (adulteration, underage sales).
Relating to Kratom Consumer Protection Act
SB 534 repeals West Virginia's 2015 kratom ban (§19-12F articles) and establishes the West Virginia Kratom Consumer Protection Act, creating a permitting and regulatory regime overseen by the Alcohol Beverage Control Administration Commissioner. The bill allows retail sale to adults 21+ subject to lab testing for purity, alkaloid concentration limits, age verification, mandatory labeling, and an 11% privilege tax.
Creates "New Jersey Kratom Consumer Protection Act."
This bill creates the New Jersey Kratom Consumer Protection Act, which regulates kratom as a food product subject to labeling, purity, and testing standards enforced by the Department of Health. It establishes an age-21 sales restriction, prohibits adulterated or contaminated products, caps alkaloid ratios, and bans synthetic kratom alkaloids. Retailers face civil penalties ($500–$1,000) and potential 3-year sales bans for violations; a mandatory state health department study is required within one year of enactment.
Establishing the kratom consumer protection act.
Washington HB 2291 establishes a state-regulated kratom consumer protection framework requiring licensing of retailers and processors, independent lab testing, mandatory labeling with health warnings, child-resistant packaging, and an 11% excise tax. The bill restricts sales to adults 21+, prohibits mail/internet delivery, bans synthetic kratom compounds and adulteration, and creates a public product directory. It preempts local jurisdictions from imposing additional product-specific licensing or fees.
Creates new provisions relating to the sale of kratom products
Missouri HB 2894 creates the Kratom Consumer Protection Act, establishing baseline safety and labeling requirements for kratom dealers. The bill prohibits sale of adulterated or contaminated kratom, synthetic alkaloids, products exceeding 2% 7-hydroxymitragynine, and kratom without labeled alkaloid content. Sales to anyone under 21 are banned, with civil liability and misdemeanor penalties for violations.
Regulates the sale of kratom in the state
Missouri Senate Bill 927 creates a regulatory framework for kratom as a food/dietary supplement under Chapter 196 RSMo. It establishes definitions for kratom products, prohibits adulteration and sales to minors, requires detailed labeling with health warnings and alkaloid quantification, and bans synthesized/semi-synthesized alkaloids and products with 7-hydroxymitragynine above 800 ppm. Violations are deemed unlawful practices under existing consumer-protection law (§407.020).
Creates new provisions relating to the sale of kratom products
HB 2652 creates the Kratom Consumer Protection Act, establishing product standards and dealer responsibilities in Missouri. It prohibits adulterated/contaminated kratom, synthetic alkaloids, and products exceeding 2% 7-hydroxymitragynine in alkaloid fraction, while requiring labeling of mitragynine and 7-hydroxymitragynine content. The bill sets a minimum age of 21 for sales and creates civil and criminal liability for violations.
Establishes the "Missouri Kratom Consumer Protection Act"
Missouri HB 2700 establishes the 'Missouri Kratom Consumer Protection Act,' creating a regulatory regime for kratom products under the Department of Health and Senior Services. The bill legalizes kratom sales to adults 21+ through registered processors meeting federal GMP and testing standards, while restricting product forms, requiring detailed labeling with alkaloid content and warnings, and prohibiting child-attractive packaging and mixing with psychoactive substances.
Creates new provisions relating to the sale of kratom products
HB 2850 creates the Kratom Consumer Protection Act, establishing statewide kratom regulation and preempting all local ordinances. The bill permits kratom sales to adults 18+, requires disclosure of alkaloid content (mitragynine and 7-hydroxymitragynine), and prohibits adulterated, contaminated, or synthetically derived kratom products. Violations trigger civil liability and criminal penalties ranging from infractions to Class D misdemeanors.
Providing for regulation of kratom.
HB 2058 establishes Pennsylvania's first statutory kratom regulation by requiring processors and retailers to register with the Department of Health, renew annually, and comply with labeling, storage, age-verification (21+), and quality standards. Fees fund addiction treatment programs. The bill bans adulterated, contaminated, and child-appealing products while authorizing a state study on kratom effects within two years.
Regards sales of kratom products
H.B. 587 creates a kratom product registration and quality-control regime in Ohio, prohibiting synthetic alkaloids and semi-synthetic compounds, mandating labeling of mitragynine and 7-hydroxymitragynine content, and banning sales to minors. Food processing establishments and retail establishments must register products with the Ohio Department of Agriculture and comply with alkaloid-composition standards enforced through civil penalties and product seizure.
Regards sales of kratom products
Ohio S.B. 299 regulates kratom as a food product rather than a drug, requiring food processing establishments and retail food establishments to register kratom products with the Director of Agriculture, disclose alkaloid content on labels, verify mitragynine is the majority alkaloid, and comply with USP solvent standards. The bill prohibits sales to minors under 18, restricts synthetic and semi-synthetic kratom alkaloids, and establishes civil penalties and product seizure procedures for non-compliance.
Relates to enacting the New York state kratom consumer protection act; relates to labeling and other requirements for the sale of kratom products.
New York Assembly Bill A08693 enacts the 'New York State Kratom Consumer Protection Act,' establishing registration and labeling requirements for kratom processors and retailers, mandating third-party lab testing for potency and contaminants, prohibiting synthesized alkaloids and products attractive to children, restricting sales to adults 21+, and imposing a 5% excise tax on retail sales.
South Carolina Kratom Consumer Protection Act
South Carolina H.B. 221 enacts the Kratom Consumer Protection Act, establishing state-level regulation of kratom products sold by retailers and processors. The bill prohibits sales to minors (under 21), mandates purity standards (no dangerous adulterants, synthetic alkaloids, or controlled substances), requires detailed labeling with alkaloid content and health disclaimers, and imposes civil penalties for violations. This is a harm-reduction/legitimization model rather than a prohibition.
Relates to enacting the New York state kratom consumer protection act; relates to labeling and other requirements for the sale of kratom products.
S08136 enacts the New York State Kratom Consumer Protection Act, establishing a regulatory framework for kratom products including registration requirements for processors and retailers, mandatory third-party laboratory testing and Certificates of Analysis, detailed labeling requirements (alkaloid content, age warnings, health disclaimers), and prohibitions on synthesized/semi-synthetic compounds, adulterated products, and sales to minors under 21. The bill also imposes a 5% excise tax on retail sales and civil/criminal penalties for non-compliance.
An act relating to the regulation of kratom products
Vermont S.121 establishes the 'Kratom Consumer Protection Act,' requiring the Department of Health to maintain a product registry, mandate independent third-party lab testing and certificates of analysis, enforce specific labeling warnings (age 21+, habit-forming, health consultation), and prohibit adulterated, synthesized, child-attractive, and unregistered kratom products. The bill creates civil and criminal penalties for violations, ranges from $5,000–$10,000 fines for unregistered sales to imprisonment for sales to minors or products containing controlled substances.
Crimes and offenses; registration of kratom products and sworn certification of compliance; provide
HB 757 creates a product registration regime for kratom in Georgia, requiring processors to register annually with the Department of Agriculture, submit certificates of analysis from independent labs, and provide sworn certifications that products are compliant with federal food facility standards, free from adulteration and synthesis, and not marketed to children. The bill also requires the Department to publish a public registry of approved products by January 1, 2026, and revises criminal penalties for violations, including reduced felony imprisonment ranges for retailers (six months to two years for first offense with criminal negligence) and a tiered misdemeanor structure for negligent retailer conduct.
An act relating to the regulation of kratom products
Vermont H.416 establishes the "Kratom Consumer Protection Act," requiring the Department of Health to maintain a registry of kratom products, set quality and extraction standards, prohibit adulteration and synthesized alkaloids, mandate independent laboratory testing and detailed labeling, restrict sales to adults 21+, and establish enforcement penalties for violations. The bill aligns kratom regulation with dietary supplement and food safety standards.
South Carolina Kratom Consumer Protection Act
South Carolina Bill 4030 enacts the Kratom Consumer Protection Act, establishing regulatory authority over kratom processors and retailers under the Department of Public Health. The bill prohibits sales to minors, bans adulteration with dangerous or controlled substances, caps 7-hydroxymitragynine at 2% of alkaloid composition, requires detailed product labeling, and enforces compliance through civil penalties. Kratom remains legal for adult use under this framework.
KRATOM CONSUMER PROTECTION
HB3215 creates the Illinois Kratom Consumer Protection Act, establishing a state registration and oversight system for kratom products. The bill mandates GMP compliance, third-party lab testing, product registration by manufacturers, and strict labeling with age-21 restrictions, while prohibiting adulterated products, synthetically altered alkaloids, and products exceeding 2% 7-hydroxymitragynine. The statute includes enforcement provisions and defers to federal regulation if the DEA or FDA act.
KRATOM CONSUMER PROTECTION
HB3127 creates the Kratom Consumer Protection Act, establishing safety and labeling standards for kratom products, prohibiting adulterated/contaminated products and those with excess 7-hydroxymitragynine or synthetic alkaloids, and imposing administrative penalties for violations. It amends the Kratom Control Act to raise the age of purchase and sale from 18 to 21 and bans kratom advertising and retail sales within 1,000 feet of schools, playgrounds, libraries, and youth facilities. Violations of age and location restrictions are Class B misdemeanors or business offenses.
Prohibiting the preparation, manufacture, sale or distribution of unsafe kratom products and the sale or distribution of kratom products to individuals younger than 21 years of age; providing for duties of Department of Health; and imposing penalties.
Pennsylvania Senate Bill 233, the Kratom Consumer Protection Act, establishes safety and quality standards for kratom products (purity, solvent limits, synthetic alkaloid prohibition, labeling requirements) and prohibits retail sales to consumers under 21 years old. The bill assigns enforcement to the Department of Health with graduated administrative fines ($100–$5,000) for violations, and includes a good-faith retailer defense. The act takes effect 60 days after passage.
KRATOM CONSUMER PROTECTION
SB1183 creates the Kratom Consumer Protection Act, replacing Illinois's prior Kratom Control Act with a regulated market framework. It restricts sale to adults 21+, mandates FDA registration and GMP compliance for processors, caps 7-hydroxymitragynine at 2% of alkaloid composition, prohibits child-attractive packaging and synthesized alkaloids, and imposes a 5% retail tax with civil and criminal penalties for violations.
Relating To Consumer Protection.
HB717 proposes the Hawaii Kratom Consumer Protection Act, requiring kratom products to be registered with the Department of Health and imposing labeling requirements effective January 1, 2026. The bill follows the KCPA model used in other states to establish regulatory oversight while permitting continued legal sales.
KRATOM CONSUMER PROTECTION
HB 1303 creates the Kratom Consumer Protection Act, establishing age-21 sales restrictions, a 5% retail tax, GMP manufacturing standards, and purity limits (capping 7-hydroxymitragynine at 2% of alkaloid composition). It prohibits adulteration with controlled substances and synthesized alkaloids, bars products attractive to children, and repeals the prior Kratom Control Act. State regulation is declared exclusive, preempting local bans.
AN ACT relating to the regulation of psychoactive substances.
HB 895 would create a new Department of Psychoactive Substances in Kentucky to regulate kratom, cannabis, and certain hemp products as "regulated products." The department would establish licensing requirements, testing standards, and enforcement procedures for these substances, while prohibiting sales to anyone under 21. This bill would bring kratom under a new regulatory framework rather than banning it, creating state-level oversight of kratom products alongside cannabis and hemp-derived substances.
Creating Intoxicating and Nicotine Retail Licensing and Public Safety Act
SB484 would create a new regulatory framework in West Virginia to license and oversee retailers selling intoxicating products, nicotine products, and controlled retail products by establishing a Division of Regulated Products & Retail Compliance. The bill's impact on kratom and kratom alkaloids would depend on whether these products are classified as "intoxicating" or "controlled retail products" under the final regulations, which could result in new licensing requirements for retailers. If kratom products fall under these definitions, the bill would regulate—rather than ban—their retail sale, but would require sellers to obtain appropriate licenses and comply with state oversight.
Food: other; regulation of distribution, sale, and manufacturing of kratom products; provide for. Creates new act.
Michigan bill proposing a new regulatory act governing kratom product distribution, sale, and manufacturing. The bill creates a framework for kratom oversight but the specific provisions—whether protective or restrictive—are not available in the metadata provided.
Kratom products; modifying certain definitions. Effective date.
SB 183 amends Oklahoma's Kratom Consumer Protection Act by updating definitional language in 63 O.S. 2021, Section 1-1432.2. The bill modifies the definitions of 'kratom leaf,' 'kratom leaf extract,' 'kratom product,' and 'vendor' to clarify existing requirements, including alkaloid content limits (3.5% total for leaf, 1% max 7-hydroxymitragynine for products) and solvent specifications. The amendment becomes effective November 1, 2025.
Study Order
H.5281 is a study order directing the Joint Committee on the Judiciary to conduct an investigation and study of House documents related to fraud, exploitation, criminal offenses, firearms, drugs, juvenile matters, and other judiciary issues. The order authorizes a committee inquiry but does not enact substantive law. It was reported from the Judiciary Committee on 3/26/2026 and referred to House Rules.
Kratom; Virginia Sate Crime Commission to conduct an analysis of enforcement and regulation, report.
This Virginia bill directs the State Crime Commission to conduct an analysis of how kratom is currently enforced and regulated within the state, with the goal of producing a report. The bill itself creates no restrictions or protections for kratom; it is purely investigative and informational in nature.
Public health: nitrous oxide.
SB 758 prohibits retailers from selling nitrous oxide at retail locations (with grocery store exemptions) and makes it a misdemeanor to sell or distribute products containing isolated 7-hydroxymitragynine, except as naturally occurring in Mitragyna speciosa. The bill explicitly protects kratom by carving out the natural plant and its products from the 7-hydroxymitragynine prohibition.
Making synthetic and semisynthetic kratom illegal to prepare, distribute, manufacture, sell, possess, or advertise, with exceptions made for scientific research.
SB 557 would make synthetic and semisynthetic kratom illegal to prepare, distribute, manufacture, sell, or possess, with an exception for scientific research only. The bill classifies such kratom as Schedule II controlled drugs. The term 'synthetic' and 'semisynthetic' covers alkaloids created by chemical synthesis, fermentation, or processes that structurally alter kratom alkaloids beyond traditional food preparation.
Relating to registration and enforcement of kratom products
West Virginia's Senate Bill 985 establishes a kratom registration and enforcement regime under the Department of Agriculture. Adults 21+ may purchase kratom products through registered retailers and online vendors with age verification; minors face possession penalties. Manufacturers, processors, and retailers must register with the state and obtain commissioner approval for products; unapproved or contaminated products trigger felony charges and license revocation.
Kratom possession legal age establishment as 21 years of age or older
S.F. 3704 amends Minnesota law to establish 21 years of age as the legal minimum for kratom possession and sale. The bill imposes a gross misdemeanor for unlawful sales to persons under 21 and a misdemeanor for unlawful possession by persons under 21. The bill was indefinitely postponed on April 22, 2026.
Requires certain kratom products to include a warning label with disclosures including, but not limited to, that kratom may be addictive and to keep it out of reach of children.
A.9443 amends New York General Business Law §398-g to expand kratom product labeling requirements. Manufacturers must disclose the product's ingredients, manufacturer/distributor identity, quantitative mitragynine and 7-hydroxymitragynine content, and warnings that kratom may be addictive, may interact with medications, is not advised for pregnant/breastfeeding individuals, and must be kept from children. The bill also requires disclosure of whether the product contains synthesized or semi-synthesized kratom alkaloids.
Prohibits the sale of kratom to individuals under the age of twenty-one; prohibits the sale or dissemination of information recorded during transaction scans; imposes a civil penalty of not more than five hundred dollars for the sale or provision of kratom to any person under the age of twenty-one; repeals certain provisions relating thereto; repeals certain provisions requiring a study on kratom; relates to the effectiveness of a chapter of the laws of 2025 relating to prohibiting the sale of kratom to persons under the age of 21.
New York S.8814 codifies a prohibition on selling kratom to persons under age 21, requires prominently posted signage, authorizes transaction scans of ID with data-use limitations, and imposes civil penalties up to $500 for violations. The bill repeals prior kratom study provisions and restructures kratom regulation under a new Article 13-I of the Public Health Law. It takes effect 180 days after enactment of the underlying 2025 legislation.
Requires certain kratom products to include a warning label with disclosures including, but not limited to, that kratom may be addictive and to keep it out of reach of children.
New York law requiring all kratom products sold in-state to display warning labels and packaging disclosures, including warnings that kratom may be addictive, is not FDA-approved, may interact with medications, and must be kept from children. The law also mandates ingredient lists, manufacturer information, quantitative alkaloid levels (mitragynine and 7-hydroxymitragynine), and disclosure of whether the product contains semi-synthesized or synthesized compounds. Civil penalties of $500–$1,000 apply to violations.
Prohibits the sale of kratom to individuals under the age of twenty-one; prohibits the sale or dissemination of information recorded during transaction scans; imposes a civil penalty of not more than five hundred dollars for the sale or provision of kratom to any person under the age of twenty-one; repeals certain provisions relating thereto; repeals certain provisions requiring a study on kratom; relates to the effectiveness of a chapter of the laws of 2025 relating to prohibiting the sale of kratom to persons under the age of 21.
This enacted law (CHAP.81, 2025) establishes an age-21 sales restriction for kratom products in New York, requires ID verification at point of sale, mandates conspicuous warning signage, and prohibits resale or dissemination of transaction-scan data. It repeals an earlier study requirement and clarifies enforcement procedures with civil penalties of up to $500 for violations.
Requires manufacturers of kratom products within the state to have a warning label that the product has not been approved by the federal food and drug administration and the products' side effects; prohibits labeling of kratom products as all natural.
This New York bill, now law, requires all kratom products sold by manufacturers in the state to carry a prominent FDA-unapproved warning label listing severe side effects including death, liver damage, and hallucinations. The law also bans any marketing or packaging that suggests kratom is 'all natural.' Violations carry civil penalties up to $500 for first offense and $1,000 thereafter, effective January 1, 2026.
Adopt the Kratom Consumer Protection Act, regulate nitrous oxide, and change the Uniform Controlled Substances Act
Nebraska LB230 adopts the Kratom Consumer Protection Act, establishing a state-regulated market for kratom products with GMP manufacturing standards, independent lab testing, product registration, age-21 sales, and comprehensive labeling requirements. The bill simultaneously regulates nitrous oxide products and updates the Uniform Controlled Substances Act schedules. The KCPA operative date is July 1, 2025, with product registration beginning no later than January 1, 2026.
AN ACT to provide for a legislative management study relating to the potential uses of kratom and the implementation of regulations of kratom in the state.
HB 1566 directs the North Dakota legislative management to conduct a study during the 2025–26 interim examining potential uses of kratom and the implementation of regulations covering production, manufacturing, distribution, and retail sale. The study findings and any recommended legislation are to be reported to the 70th legislative assembly, with no immediate regulatory changes or restrictions.